Fuda Cancer Hospital
| 中国 | トルコ | オーストリア | |
| 放射線療法 | から $10,500 | から $3,250 | から $18,000 |
| 大腸癌に対する放射線療法 | から $11,500 | から $7,000 | から $12,000 |
| 乳癌化学療法 | から $14,800 | から $1,200 | から $15,000 |
| ガンマナイフ | から $7,800 | から $6,300 | から $32,000 |
Bookimedは骨肉腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。骨肉腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。骨肉腫治療の旅路でお一人になることはありません。
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
China uses a multimodal protocol for osteosarcoma. This strategy combines neoadjuvant chemotherapy, surgical limb-salvage, and postoperative adjuvant chemotherapy. Doctors follow guidelines from the Chinese Society of Clinical Oncology. These protocols prioritize high-dose drug regimens and precision surgery to maximize survival. Successful treatment often involves intensive inpatient care.
Bookimed Expert Insight: Chinese oncology centers often favor a high-intensity inpatient chemotherapy model. Fuda Cancer Hospital stands out by offering over 10 types of minimally invasive therapies. This variety allows doctors to treat advanced cases where standard surgery might be difficult. Their focus on technology like NanoKnife provides options for late-stage patients from over 100 countries.
Patient Consensus: Patients note that treatment is strictly protocol-driven but emphasize seeking second opinions before surgery. They emphasize that access to the best outcomes often requires traveling to specialized high-volume cancer hospitals.
China provides advanced osteosarcoma therapies including targeted agents and cell-based immunotherapies. Specialized centers utilize multi-kinase inhibitors and cryosurgical ablation for metastatic cases. The country hosts 14% of global osteosarcoma clinical trials. Leading facilities integrate genomic profiling with precision oncology protocols for refractory bone tumors.
Bookimed Expert Insight: Clinical data from JCI-accredited facilities like Fuda Cancer Hospital indicates a shift toward multi-modal management. Their approach uses over 10 types of minimally invasive therapies to manage late-stage cancer. We observe that high-volume centers serving over 30,000 international patients often combine immunotherapy with vascular interventional therapy. This strategy aims to improve tumor response when traditional chemotherapy has reached its limits.
Patient Consensus: Patients emphasize that finding an experienced orthopedic oncology team is more important than the hospital's general reputation. Many recommend verifying if a facility performs complex limb-salvage surgery frequently before starting any advanced or alternative therapy plan.
China is home to top-rated oncology centers like Fuda Cancer Hospital and Xiamen Humanity Hospital. These facilities specialize in limb-salvage surgeries and advanced ablation. Many hold JCI accreditation and employ multidisciplinary teams. They treat complex sarcomas using precise radiotherapy and targeted protocols.
Bookimed Expert Insight: Patient volume is a major quality indicator in China. Fuda Cancer Hospital treats over 30,000 patients annually and maintains a 4.6-star rating. This high volume often correlates with better surgical outcomes in rare bone cancers. We recommend choosing centers with dedicated bone tumor departments rather than general clinics.
Patient Consensus: Patients emphasize finding surgeons who perform limb-sparing procedures weekly. They note that having pathology, imaging, and chemotherapy under one roof is essential for success.
Traditional Chinese Medicine (TCM) serves as a supportive adjuvant therapy alongside surgery and multi-agent chemotherapy in China. It optimizes outcomes by mitigating side effects and supporting the immune system. Integrated protocols often include acupuncture and herbal formulations to improve patient quality of life and tolerance for intense oncology regimens.
Bookimed Expert Insight: While major centers like Xiamen Humanity Hospital focus on high-precision radiotherapy, facilities like Fuda Cancer Hospital in Guangzhou demonstrate the regional trend of offering over 10 types of minimally invasive therapies to reduce reliance on aggressive systemic chemotherapy. This shift allows TCM to play a more proactive role in recovery since patients maintain higher baseline strength than those on standard high-dose protocols.
Patient Consensus: Patients note that TCM is most effective for regaining appetite and sleep during recovery. They emphasize that while herbal medicine provides holistic comfort, it must never delay surgery for this aggressive cancer.
International patients can access specialized oncology care in China effectively by utilizing JCI-accredited facilities and dedicated international medical wings. Modern centers provide rapid diagnostic turnaround and advanced therapies. Navigating the system requires pre-arranged medical visas, digital payment setup, and coordination via international patient departments.
Bookimed Expert Insight: Data from Fuda Cancer Hospital shows they have treated over 30,000 patients from 100 countries. This high international volume indicates that choosing major tertiary centers in cities like Guangzhou or Xiamen simplifies the paperwork process. These clinics are better equipped to handle foreign passports and provide the necessary official invitation letters for visa approval.
Patient Consensus: Patients note it is vital to bring all imaging and pathology records in digital form. Having a bilingual advocate or using a dedicated international desk makes navigating daily hospital tasks much smoother.